Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Revenue (2023 - 2024)

Praxis Precision Medicines has reported Revenue over the past 2 years, most recently at $7.5 million for Q4 2024.

  • Quarterly results put Revenue at $7.5 million for Q4 2024, up 1349.13% from a year ago — trailing twelve months through Sep 2025 was $7.5 million (up 364.98% YoY), and the annual figure for FY2024 was $8.6 million, up 249.53%.
  • Revenue for Q4 2024 was $7.5 million at Praxis Precision Medicines, up from $302000.0 in the prior quarter.
  • Over the last five years, Revenue for PRAX hit a ceiling of $7.5 million in Q4 2024 and a floor of $302000.0 in Q3 2024.